?? ??⭐??? ???⭐?? ??? ??? ?? ??? ???? ???? ??? ???? ?????.

1. ?? ??⭐??? ???⭐?? ??? ??? ?? ??? ???? ???? ??? ???? ?????.?? ??????? ?? ? ???? ???? ??? ????.?????, ???? ??? ????? ??? ??? ??? ???? ???? ???? ???? ???? ????. “??? ???? ??? ?? ??? ??? ????? ????? ???? ??.”??? ???? 29? ?? ?????? ?? ??? ??????? ?? ???? ??? ?? ??? ????. ?? 2007? ?? 17? ? ???? ??? ?? ?? ??? ??? ?????, ??? ??? ??? ??? ??? ?? ???? ??? ?? ?????.

2. ???? ? ?????? ??⭐??? ???⭐??? ???? ???? ??? ?? ???? ?????? ??? ???? ?? ???, ???? ?? ? ???? ???? ?? ?? ?? ??? ??? ????.

3. ?????? ??⭐??? ???⭐The buyer in the transaction was U.S.-based fund manager Brookdale Asset Management, which manages assets totaling $3 billion.Lunit explained the block deal as part of Guardant Health’s financial strategy to partially realize investment returns, noting that it has been three years since the initial investment. ???????? ?? ??? ?? ?? ???? ????. ???? ??? ??? ?? ??? ???? ???? ?? ??? ?? ???? ??. ???????? ?? ‘???’ ??? ????? ???? ??? ?? ???? ????? ??.

4. ???????? ??⭐??? ???⭐nba odds to win titleYunovia received approval from the Ministry of Food and Drug Safety during the previous week for its clinical trial plan for the MAD study, which will evaluate ID110521156’s safety, tolerability, and pharmacodynamics properties. The company has already demonstrated the efficacy of the drug candidate in insulin secretion and blood glucose control animal tests, as well as its higher level of safety compared to similar competitive drugs.